Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Curanex shares rose after a cancer cachexia patient showed improvements.

flag Shares of Curanex Pharmaceuticals rose Monday after a patient case study showed improvements in energy and lab markers for Phyto-N, a compound under development for cancer cachexia. flag The patient, a dosimetrist with a pancreatic tumor, experienced notable changes within a month. flag The company emphasized the potential of this unmet medical need and is advancing Phyto-N through preclinical work.

3 Articles